EUVIMEDEUVIMED entdecken
Crossref

Gender Disparity of Automatic Implantable Cardioverter-Defibrillator Placement for Primary Prevention: National Inpatient Sample Analysis

Shreya Srivastava, Meghan Nahass, Emily Hiltner, Ankur Sethi, John Kassotis

Cardiology · 2024

DOI: 10.1159/000540696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology, 2024. Verfasst von Shreya Srivastava und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA, ssrivastava3@northwell.edu. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Primary Prevention, Death, Sudden, Cardiac, Heart Failure, Systolic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Automatic implantable cardioverter-defibrillators (AICDs) for the primary prevention of sudden cardiac death have become standard care for patients with systolic heart failure (sHF) and ejection fraction ≤35%. While the prevalence of sHF and rates of hospitalization are higher in men, one would expect equivalent rates of implantation in women.

Methods

We used the Healthcare Cost and Utilization Project’s National Inpatient Sample (NIS) from 2009 to 2018 to identify patient visits with sHF and AICD implantation. The comorbidities and outcomes were compared based on gender.

Results

There were 15,247,854 inpatient admissions for sHF, of which 60.3% were males (95% CI: 60.1%–60.4%) and 39.8% females (95% CI: 39.7%–39.9%). Approximately 2% of patients (294,726) underwent the insertion of an AICD for primary prevention: 72.3% males (95% CI: 71.9%–72.7%) and 27.72% females (95% CI: 27.3%–28.1%). There was no significant difference in age (p = 0.29), length of stay (p = 0.09), and inpatient mortality (p = 0.18).

Conclusion

In this study, women accounted for approximately 40% of patients admitted with the diagnosis of sHF; however, they accounted for less than 30% of patients who underwent the insertion of an AICD. Further research is needed to better understand this gender disparity and identify reasons for the lower rates of AICD placement in women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantablePrimary PreventionDeath, Sudden, CardiacHeart Failure, SystolicHumansMaleFemaleMiddle AgedAgedUnited StatesSex FactorsInpatientsHospitalization

Stichwörter der Autor:innen

Automatic implantable cardioverter-defibrillatorGender disparitiesNational inpatient samplePrimary prevention

Autor:innen und Institutionen

  • Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA, ssrivastava3@northwell.edu.
  • Department of Medicine, Division of Cardiology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Department of Cardiology, Peconic Bay Medical Center Northwell Health, Riverhead, New York, USA.

Zitieren

APA

Srivastava, S., Nahass, M., Hiltner, E., Sethi, A., & Kassotis, J. (2024). Gender Disparity of Automatic Implantable Cardioverter-Defibrillator Placement for Primary Prevention: National Inpatient Sample Analysis. Cardiology. https://doi.org/10.1159/000540696

Vancouver

Srivastava S, Nahass M, Hiltner E, Sethi A, Kassotis J. Gender Disparity of Automatic Implantable Cardioverter-Defibrillator Placement for Primary Prevention: National Inpatient Sample Analysis. Cardiology. 2024. doi:10.1159/000540696

BibTeX
@article{Srivastava2024,
  author = {Srivastava, Shreya and Nahass, Meghan and Hiltner, Emily and Sethi, Ankur and Kassotis, John},
  title = {Gender Disparity of Automatic Implantable Cardioverter-Defibrillator Placement for Primary Prevention: National Inpatient Sample Analysis},
  journal = {Cardiology},
  year = {2024},
  doi = {10.1159/000540696}
}
Kostenlos starten →